Unlike many cancers, retinoblastoma is characterized by a p53 wild-type (p53wt) phenotype, making the pharmacological reactivation of the p53 pathway a realistic option to induce cell cycle block and apoptosis. This evidence concerns the gene TP53 and retinoblastoma.